SCHEMBL4985172

SCHEMBL4985172

CCCCOC(C)(CC(C)C)OCCCC

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.33
ADRB1 P08588 1/20 0.33
ADRB3 P13945 1/20 0.33
CYP3A4 P08684 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9497953 0.86 HSD17B10 (0.31)
SCHEMBL10897733 0.77 ADRB2 (0.30) ADRB2ADRB1ADRB3
SCHEMBL27186208 0.77 ADRB2 (0.30) ADRB2ADRB1ADRB3
SCHEMBL4982402 0.75 MMP8 (0.35)
SCHEMBL4980904 0.75 TSHR (0.42) ADRB2ADRB1ADRB3CYP3A4TSHR
SCHEMBL13870427 0.74
SCHEMBL22960180 0.73 TSHR (0.44) ADRB2ADRB1ADRB3CYP3A4TSHR
SCHEMBL9500960 0.73 CYP3A4 (0.39) ADRB2ADRB1ADRB3CYP3A4TSHR
SCHEMBL9498867 0.73 ADRB2 (0.38) ADRB2ADRB1ADRB3CYP3A4TSHR
SCHEMBL19941716 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105017841-B Organic solvent dispersion of titanium oxide solid solution particles, method of preparation and coating composition 信越化学工业株式会社 2020-01-17 CN disclosed
CN-104610877-B The product of coating composition and coating containing titanium oxide 信越化学工业株式会社 2019-04-23 CN disclosed
EP-2933230-B1 ORGANIC SOLVENT DISPERSION OF TITANIUM OXIDE SOLID-SOLUTION PARTICLES, MAKING METHOD AND COATING COMPOSITION SHINETSU CHEMICAL CO (JP) 2018-01-03 EP disclosed
EP-2865720-B1 Photocurable coating composition, laminate, and automotive headlamp covering sheet SHINETSU CHEMICAL CO (JP) 2017-05-03 EP disclosed
EP-2868717-B1 Titania-containing coating composition and coated article SHINETSU CHEMICAL CO (JP) 2017-04-19 EP disclosed
EP-2952480-A1 TITANIUM OXIDE SOLID SOLUTION DISPERSION AND COATING COMPOSITION Shin-Etsu Chemical Co., Ltd. (JP) 2015-12-09 EP disclosed
US-20150299417-A1 ORGANIC SOLVENT DISPERSION OF TITANIUM OXIDE SOLID-SOLUTION PARTICLES, MAKING METHOD, AND COATING COMPOSITION SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-10-22 US disclosed
EP-2933230-A1 ORGANIC SOLVENT DISPERSION OF TITANIUM OXIDE SOLID-SOLUTION PARTICLES, MAKING METHOD AND COATING COMPOSITION Shin-Etsu Chemical Co., Ltd. (JP) 2015-10-21 EP disclosed
US-20150125707-A1 TITANIA-CONTAINING COATING COMPOSITION AND COATED ARTICLE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-05-07 US disclosed
EP-2868717-A1 Titania-containing coating composition and coated article Shin-Etsu Chemical Co., Ltd. (JP) 2015-05-06 EP disclosed
US-20150118483-A1 PHOTOCURABLE COATING COMPOSITION, LAMINATE, AND AUTOMOTIVE HEADLAMP COVERING SHEET SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-04-30 US disclosed
EP-2865720-A1 Photocurable coating composition, laminate, and automotive headlamp covering sheet Shin-Etsu Chemical Co., Ltd. (JP) 2015-04-29 EP disclosed
US-20080053835-A1 Monomer Compound, Process for Producing the Same, Polymer Thereof, and Water-Based Curable Composition KANSAI PAINT CO., LTD. (JP) 2008-03-06 US disclosed
EP-1798218-A1 MONOMER COMPOUND, PROCESS FOR PRODUCING THE SAME, POLYMER THEREOF, AND WATER-BASED CURABLE COMPOSITION KANSAI PAINT CO., LTD. (JP) 2007-06-20 EP disclosed
EP-0272110-B1 ERYTHROMYCIN A DERIVATIVES AND METHOD FOR THE PREPARATION OF THE SAME TAISHO PHARMACEUTICAL CO. LTD (JP) 1993-04-07 EP disclosed
US-4990602-A Bactericides TAISHO PHARMACEUTICAL CO., LTD. (JP) 1991-02-05 US disclosed
EP-0272110-A2 Erythromycin a derivatives and method for the preparation of the same TAISHO PHARMACEUTICAL CO. LTD (JP) 1988-06-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080053835-A1 Monomer Compound, Process for Producing the Same, Polymer Thereof, and Water-Based Curable Composition THEM6, PAM, WEE1 ADRB2 3892/4885ADRB1 3306/4885ADRB3 4409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.